Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
Marc-Kevin Le RouxNicolas GraillonLaurent GuyotDavid TaïebPhilippe GalliYves Godio-RaboutetCyrille ChossegrosJean-Marc FolettiPublished in: Head & neck (2020)
Our study suggests that a significant rate of patients will recover from I131 therapy salivary side effects. As almost 30% of these remissions happened during our late stage follow-up, we highlight the necessity of a long-term follow-up in these patients.